Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > How Barclays Capital values Small Cap Oncology names

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Feb 04, 2021 8:39am

68 Views

Post# 32468418

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How Barclays Capital values Small Cap Oncology names

You'd be highly welcomed by the market makers. If past pattern holds, you will make money. FYI - it appears the "fast track" designation is handed out pretty often. You do have to apply, so THTX is pushing. I think there are further designations to come -- the best being Break Through Therapy. So I guess it highlights you are on the path with the FDA. Definitely makes the regulatory process easier as you can piece-meal file the parts of you applications as you finish it in the trials.

So good news, but like you say, uneducated algo traders just jumping in pre market. I do hope it corrects for all this dilution puke though . Let's hold that $3!!!!